ライフサイエンスコーパス: IgE

1 IgE and IgG4 levels to selected peptides were quantified

2 IgE antibodies are best known for pathogenic roles in al

3 IgE antibody responses initiated by these variant transc

4 IgE binding to almond extract and the allergens was anal

5 IgE binding to one peptide on Ara h 5 and IgG4 binding t

6 IgE binding was tested by means of ELISA with sera from

7 IgE crossed the placenta, dependent on the fetal neonata

8 IgE is the central antibody isotype in TH2-biased immuni

9 IgE is the least abundant circulating antibody class but

10 IgE levels to 27 Culicoides r-allergens, including 8 pre

11 IgE production against innocuous food antigens can resul

12 IgE reactivity analysis in 28 patients allergic to chick

13 IgE reactivity was assessed using sera from milk-sensiti

14 IgE to 112 allergenic molecules (components, c-sIgE) was

15 IgE to Pru du 6 maintained high sensitivity (83%) and pr

16 IgE to Pru du 8 and Pru du 10 was less sensitive (41% an

17 IgE to the biguanide and/or hexamethylene structure was

18 IgE-bearing basophils are recruited to inflamed skin via

19 IgE-binding to fish tropomyosins and TPIs was demonstrat

20 IgE-mediated food allergy remains a significant and grow

21 IgE-mediated reactions towards these neoantigens are wel

22 IgE-reactive proteins were purified from almond kernels.

23 hypoallergenic Ara h 2 mutant with abolished IgE binding and anaphylactogenic potency but retained T-

24 hat blockade of IL-4/IL-13 signaling aborted IgE production after activation of a recall response and

25 vels, protected mice from passive and active IgE sensitization, and resulted in cross-protection agai

26 allergic conditions (atopic dermatitis [AD], IgE-mediated food allergy [IgE-FA], asthma, and allergic

27 ls and airway eosinophilia without affecting IgE levels or airway hyperresponsiveness.

28 ion caused by cross-linking of high-affinity IgE antibodies on the surface of mast cells and basophil

29 llular mechanisms that lead to high-affinity IgE production is required to develop better therapeutic

30 release between WT and Fn14(-/-) BMMCs after IgE-FcepsilonRI stimulation.

31 h SCFAs and assessed for degranulation after IgE- or non-IgE-mediated stimulation.

32 ylation and Ca(2+) flux, were measured after IgE crosslinking in murine bone marrow-derived mast cell

33 dermatitis [AD], IgE-mediated food allergy [IgE-FA], asthma, and allergic rhinitis [AR]) was ascerta

34 lasma from alpha-gal allergic subjects in an IgE-dependent manner suggesting a role for glycolipid in

35 cold-induced formation of autoallergens and IgE to these autoallergens, which provoke a release of p

36 nvestigate the contribution of basophils and IgE in the lung pathology development of this mouse mode

37 ght to investigate the role of basophils and IgE in the pathophysiology of MCTD.

38 cum, and a complete absence of mast cell and IgE production.

39 Single IgG(E)(+) memory B-cell and IgE(+) preplasmablast transcriptomes encoded antibodies

40 Basophil depletion and IgE-deficient animals were used to investigate the contr

41 IL-13, with infiltration of eosinophils and IgE-coated mast cells in clinical specimens of BIA-ALCL.

42 Common IgG and IgE epitopes were identified between both allergens.

43 ep score, Dermatology Life Quality Index and IgE.

44 SsNP was associated with STAT6 signaling and IgE-mediated activation controlled by eosinophils, mast

45 Anti-IgE (omalizumab) has been used for the treatment of mode

46 ed towards the directed evolution of an anti-IgE Affibody (ZIgE), generating a 160,000-membered, 4-si

47 HR induced by anti-IgE was significantly increased at 08:00 vs. 20:00 in ba

48 be downregulated by glycan-specific IgG anti-IgE autoantibodies.

49 d then incubated with concentrations of anti-IgE, formyl-methionyl-leucylphenylalanine (fMLP), or the

50 olecular properties of past and present anti-IgE biologicals and suggest concepts that might improve

51 l lung function, and in those receiving anti-IgE.

52 The anti-IgE autoantibodies prevented effector cell sensitization

53 is currently still only one therapeutic anti-IgE antibody approved for the treatment of allergic cond

54 way for the development of therapeutic anti-IgE biologicals as we know them today.

55 The basophil response to anti-IgE, but not fMLP or A23187, varied significantly across

56 in both, stimulation for 24 hours with anti-IgE, C5a, fMLP, and IL-3 in basophils and by IL-3, IL-5,

57 r FcepsilonRI, and administering asialylated IgE-markedly reduce anaphylaxis.

58 Autoreactive IgE raised against the main MCTD autoantigen U1 small nu

59 Understanding the discrepancy between IgE sensitization and allergic reactions to peanut could

60 still not fully understood where in the body IgE class switch recombination of food allergen-specific

61 cluding removing sialic acid from cell-bound IgE with a neuraminidase enzyme targeted towards the IgE

62 E binding and displacement of receptor-bound IgE were assessed using cellular assays, basophil activa

63 th nasal polyps (CRSwNP) is characterized by IgE hyperproduction and eosinophilic inflammation.

64 e a major clinical problem and are driven by IgE antibodies (Abs) specific for food antigens (Ags).

65 nst parasitic infestation, often mediated by IgE Fc receptor-expressing macrophages.

66 h 1, Ara h 2, and Ara h 3 were bound more by IgE of PA compared to PS patients on the microarray.

67 Because anti-CCD IgE has limited clinical relevance, it may impact ARD ph

68 Later increases in circulating IgE, which can induce mast cell degranulation, as well a

69 courses in consecutive years on circulating IgE(+) and IgG(+) memory B cells and allergen-specific I

70 The mechanisms that control IgE activity and prevent anaphylaxis under normal condit

71 In high-income, temperate countries, IgE to allergen extracts is a risk factor for, and media

72 , suggesting that EPIT specifically decrease IgE-mediated anaphylaxis.

73 nOVAmax pretreated mice had decreased IgE as well as IgG1 and IgG2a levels and Treg numbers we

74 ents and outcomes of infants who demonstrate IgE sensitization to foods that they clinically tolerate

75 Using glycan arrays, we dissected IgE responses to specific glycan moieties and found that

76 exposure by SLIT resulted in highly diverse IgE and IgG(E) repertoires.

77 te isomerase (Asp t 36), one of the dominant IgE (IgE)-reactive proteins.

78 NFAT DsRed IgE reporter cell binding was significantly increased on

79 rick and allergen-specific immunoglobulin E (IgE) (ImmunoCAP((R))) tests.

80 fter the identification of immunoglobulin E (IgE) and its key role in allergic hypersensitivity react

81 yzed a published model for immunoglobulin E (IgE) receptor signaling using synthetic qualitative and

82 Targeting of immunoglobulin E (IgE) represents an interesting approach for the treatmen

83 that are often mediated by immunoglobulin E (IgE).

84 Immunoglobulins E (IgEs) trigger allergic reactions by specifically binding

85 opic individuals develop abnormally elevated IgE responses to immunization with potential allergens.

86 lysis and peptidolipid/lipid binding, elicit IgE and stimulate bystander responses to unrelated aller

87 a, allergic asthma, total IgE, environmental IgE, and FeNO in an independent cohort of children.

88 Together, these results establish IgE glycosylation, and specifically sialylation, as an i

89 ive intestinal mastocytosis and experimental IgE-mediated food allergy.

90 C9 function and exacerbation of experimental IgE-mediated food allergic reactions.

91 ic manipulation produced significantly fewer IgE Abs to peanuts compared with control mice.

92 en with AD (age 0-3 years) were analyzed for IgE and 33 cytokines, chemokines, and growth factors.

93 es available at all 3 ages were analyzed for IgE reactivity to 8 Phleum pratense (Phl p) allergens (M

94 15 to 16 (n = 5825) years were analyzed for IgE sensitization to allergen extracts by ImmunoCAP.

95 n of 0.26 IU/mL (624 pg/mL) and 14 ng/mL for IgE and IgG antibodies, respectively.

96 ress robustly the high-affinity receptor for IgE, FcepsilonRI, and thereby sense allergens.

97 be a new algorithm with high sensitivity for IgE-mediated food allergy in clinical study participants

98 lides, and patients' samples were tested for IgE and IgG4 binding using immunofluorescence.

99 slate to distinct biological functions: free IgE initiated allergic inflammation through FcepsilonRI

100 An increasing number of people suffer from IgE-mediated food allergies.

101 ate a dominant protective role of functional IgE-blocking IgG1 antibodies in the early phase of aller

102 ical properties of a different class ( e.g., IgE) could engender potent effector cell activation, and

103 IgG4 levels are elevated in AERD, and higher IgE levels are associated with faster nasal polyp regrow

104 d-allergic subjects had significantly higher IgE levels to almond extract (P < .0001) and Pru du 6 (P

105 these neoantigens are well studied; however, IgE-independent reactions are less well understood.

106 grass pollen extract, polyclonal anti-human IgE) were printed onto three different polymer-coated su

107 Autosomal dominant hyper-IgE syndrome (AD-HIES) is typically caused by dominant-n

108 omerase (Asp t 36), one of the dominant IgE (IgE)-reactive proteins.

109 , and the effects of LamOVA on blocking IgG, IgE, cellular composition of BAL, lung, and spleen, lung

110 IgE, level of peanut-specific IgE, and IgG4/IgE ratio also had 100% sensitivity but slightly lower s

111 es, with no anticipated effects on IgA, IgM, IgE, complement, plasma cells, B cells, or other cells o

112 Using ImmunoCAP, IgE to the Ara h 2 peptides enhanced the diagnostic accu

113 ing to its promotor and subsequently impairs IgE-mediated signaling.

114 rationresulting in a significant decrease in IgE-binding potency.

115 have both helper and suppressor functions in IgE production in the germinal center (GC) that work tog

116 sting at 170 degrees C caused a reduction in IgE-binding, which was particularly noticeable after inf

117 c patients sera indicated a 50% reduction in IgE-reactivity upon EDTA presence.

118 that the 2 receptors exert distinct roles in IgE handling.

119 ciated with higher levels of therapy-induced IgE and TH2 cytokines.

120 e the primary source of IL-21 that inhibited IgE responses by directly engaging the IL-21 receptor on

121 to the IgE Fc fragment, the IgE Fc in intact IgE is significantly less asymmetrically bent.

122 The structure of intact IgE and the impact of IgE-targeting molecules on IgE how

123 r data reveal the first structures of intact IgE suggesting that the IgE Fab is fixed relative to the

124 gation of laminarin to ovalbumin reduced its IgE binding capacity fivefold and increased its immunoge

125 By removing conformational and linear IgE epitopes, a hypoallergenic Ara h 2 mutant with aboli

126 tive importance of conformational and linear IgE-binding epitopes of the major peanut allergen Ara h

127 idly switch isotype, expand into short-lived IgE(+) plasmablasts, and serve as a potential target for

128 es of epitopes displayed significantly lower IgE binding (median ELISA OD, 0.03; interquartile range,

129 pregnancy and can be sensitized by maternal IgE.

130 Repeated antigen encounter elicits a memory IgE response with elevated serum IgE titers and accumula

131 opulation of IgE-producing PCs during memory IgE responses.

132 transmembrane IgE (mIgE) impairs the memory IgE response in mice.

133 acalabrutinib completely prevented moderate IgE-mediated anaphylaxis in these mice and also signific

134 Rapid desensitization of naive, IgE-sensitized huFcepsilonRIalpha mice and huFcepsilonRI

135 These findings indicate that natural IgE antibodies support skin barrier defences, but that d

136 time (5 h) might lead to the exposure of new IgE - reactive epitopes.

137 Non-IgE-mediated allergy, outside of food protein-induced al

138 a mast cell-specific receptor mediating non-IgE-dependent activation.

139 to establish diagnosis and management of non-IgE-mediated allergies in breastfed infants.

140 hed, to explore the clinical spectrum of non-IgE-mediated allergies, and part of its objectives was t

141 assessed for degranulation after IgE- or non-IgE-mediated stimulation.

142 r cells led to greatly increased nonspecific IgE levels, showing that Tfr cells have both helper and

143 FcepsilonRIalpha mAbs safely removed >98% of IgE from peritoneal mast cells and completely suppressed

144 levated serum IgE titers and accumulation of IgE-producing PCs.

145 the serum level and anaphylactic activity of IgE may be downregulated by glycan-specific IgG anti-IgE

146 In the immunoblot assay, binding of IgE antibody was observed with CC38K (the main component

147 Simultaneous binding of IgE to FcepsilonRI and CD23 is blocked by reciprocal all

148 In case of IgE antibodies, the lowest binding capacity was detected

149 ht to allow description of the complexity of IgE, IgG(4), and IgG epitope recognition at a global, al

150 Moreover, the demanding low concentration of IgE, compared to other analytes in real serum samples, m

151 nded and twofold symmetrical conformation of IgE, which retains a rigid Fab-Fc architecture.

152 lergy is characterized by the development of IgE against peanut antigen.

153 cells play a key role in the development of IgE-mediated food allergies through the production of al

154 The cellular origin and evolution of IgE responses are poorly understood.

155 from catfish displayed a higher frequency of IgE-binding compared to those from salmon (77% vs 70% an

156 erum IgE levels as well as the generation of IgE-producing germinal center B cells and PCs subsequent

157 he structure of intact IgE and the impact of IgE-targeting molecules on IgE however remain elusive.

158 Inhibition of IgE binding and displacement of receptor-bound IgE were

159 Immunological perspective: A high level of IgE cross-reactivity towards allergens from the birch ho

160 e, that skin inflammation enhances levels of IgE antibodies that have natural specificities and a rep

161 reated with TGFbeta1-mim had lower levels of IgE, IgG1, IgG2a and higher levels of IgA antibodies tha

162 d bone marrow reconstitution-based models of IgE-mediated food allergy revealed an IL-4 signaling-dep

163 role for glycolipid in the effector phase of IgE-mediated food allergy.

164 stablishing or maintaining the population of IgE-producing PCs during memory IgE responses.

165 key features of the extrinsic regulation of IgE production by cytokines.

166 This study supports a direct role of IgE in AAA by promoting lesion chemokine expression, inf

167 This study tests a direct role of IgE in angiotensin-II (Ang-II) perfusion- and peri-aorti

168 allergy, so justifying the positive role of IgE in our evolution.

169 rtant role in allergies through secretion of IgE.

170 9) fragment can be considered as the site of IgE recognition of Rhi o 2.

171 ch), and Ani s 3 (fish parasite)-in terms of IgE binding, structural stability, endolysosomal degrada

172 nd CDRH3 characteristics similar to those of IgE antibodies in healthy tissue.

173 d their interaction with blocking omalizumab-IgE complexes and free omalizumab levels in serum (chi(2

174 reover, this acquired protection depended on IgE effector mechanisms and MCs.

175 and the impact of IgE-targeting molecules on IgE however remain elusive.

176 ofile, (c) decrease in GALNS-specific IgG or IgE in plasma, (d) decreased GAG storage in liver, and (

177 OVA-IgE and OVA-IgG1 serum levels were not significantly alt

178 Overall, IgE sensitization to extracts was highly prevalent (43%-

179 Patients' IgE recognized conformational and linear epitopes in a p

180 Profiles of patients' IgE reactivity to chicken muscle were analyzed in immuno

181 Allergic asthma with high plasma IgE levels is a significant risk factor of human abdomin

182 Positive IgE (>=0.35 kU/L) to almond extract showed 94% sensitivi

183 In the tropics, positive IgE tests are also prevalent, but rarely associated with

184 afe, effective, and practical way to prevent IgE-mediated anaphylaxis.

185 ed that irreversible BTKis broadly prevented IgE-mediated degranulation and cytokine production in pr

186 ar, no precise information on cross-reactive IgE-epitopes of cyclophilins is available.

187 ssing the antitumor potential of recombinant IgE antibodies in cancer patients is also discussed.

188 We demonstrate that EPIT markedly reduced IgE-mediated allergic reactions in a mouse model of cash

189 -binding sites and revealed strongly reduced IgE reactivity.

190 -specific case history supported by relevant IgE sensitization.

191 E outperformed different clinically relevant IgE cutoffs, predicting allergy status on an "unseen" se

192 gical function of allergic immune responses, IgE antibodies, and MCs in host defense against a pathog

193 do1 expression and was sufficient to restore IgE production and worm expulsion in inulin-fed mice.

194 and its effects on muscle and parvalbumin's IgE-reactivity were analyzed.

195 The protein's IgE reactivity was analyzed in ELISA experiments, and cr

196 Levels of specific (s)IgE and sIgG(4) to peanut and component proteins, and 50

197 g 5 epitopes were recognized by patient sera IgE.

198 nactivated mIgE-ITT motif and analyzed serum IgE levels as well as the generation of IgE-producing ge

199 nchoalveolar lavage fluid albumin, and serum IgE levels.

200 with ovalbumin resulted in diminished serum IgE titers and reduced mast cell activation.

201 ts a memory IgE response with elevated serum IgE titers and accumulation of IgE-producing PCs.

202 antly reduced Th2 cytokine production, serum IgE levels, and airway hyperreactivity.

203 athologies including allergen-specific serum IgE production, allergic lung and airway inflammation an

204 us within the airway did not relate to serum IgE positivity for Aspergillus.

205 atient reacted primarily with OCT and showed IgE cross-reactivity with CHX, ALX, and PHMB.

206 se, and glucose-6-phosphate isomerase showed IgE-binding for 6%-13% of patients.

207 e TGase crosslinked hydrolysates had similar IgE-binding properties to the un-crosslinked hydrolysate

208 Specific IgE had a summary sensitivity of 19.3% (95% CI, 12.0%-29

209 duced functional, primarily Mal d 1-specific IgE-blocking antibodies, whereas rBet v 1 SLIT induced B

210 Ara h 2-specific IgE and Ara h 6-specific IgE provide the greatest accura

211 ut-specific IgE, Arachis hypogaea 2-specific IgE, and peanut-specific IgG4, and we analyzed the utili

212 he SPT, level of Arachis hypogaea 2-specific IgE, level of peanut-specific IgE, and IgG4/IgE ratio al

213 the diagnostic accuracy of Ara h 2-specific IgE.

214 E added diagnostic value to Ara h 2-specific IgE.

215 Ara h 2-specific IgE and Ara h 6-specific IgE provide the greatest accuracy to diagnose peanut all

216 to facilitate the production of Ag-specific IgE.

217 helper function by Tfr cells on Ag-specific IgE.

218 at includes levels of free allergen-specific IgE and their interaction with blocking omalizumab-IgE c

219 ully used for detection of allergen-specific IgE in patient sera.

220 mined risks of transfer of allergen-specific IgE or IgG responses 24 months post-transplantation.

221 ntation profoundly reduces allergen-specific IgE responses but also comes with a considerable risk to

222 s allow for measurement of allergen-specific IgE responses to multiple extracts and molecular allerge

223 ll transplantation, 94% of allergen-specific IgE responses were lost.

224 he immunological memory of allergen-specific IgE responses.

225 Allergen-specific IgE tests (ImmunoCAP ((R))) showed positivity for shrimp

226 statistical integration of allergen-specific IgE to peanut/tree nut allergens from three IgE test pla

227 ansplantation, recipients' allergen-specific IgE was significantly linked to the pretransplantation d

228 biotas of sensitized (determined by specific IgE results at 18 months of age) and unsensitized Estoni

229 with and cross-link preformed drug-specific IgE.

230 Serum was assessed for A fumigatus-specific IgE and total IgE.

231 may occur in individuals who lacked specific IgE when tested using native protein reagents.

232 clinical groups, was independent of specific IgE concentration.

233 r multiparametric quantification of specific IgE to penicillin G, penicillin V, amoxicillin, and pipe

234 lergy and in whom skin tests and/or specific IgE quantification were performed and compared with drug

235 Early epitope-specific plus peanut-specific IgE is predictive of allergy status at age 4(+) years.

236 nes strongly correlated with peanut-specific IgE levels.

237 nsplantation, newly acquired peanut-specific IgE were transiently detected from 1 donor to 3 recipien

238 aea 2-specific IgE, level of peanut-specific IgE, and IgG4/IgE ratio also had 100% sensitivity but sl

239 and measuring the levels of peanut-specific IgE, Arachis hypogaea 2-specific IgE, and peanut-specifi

240 ad markedly higher levels of peanut-specific IgE, revealing an active helper function by Tfr cells on

241 Ara h 2 peptide-specific IgE added diagnostic value to Ara h 2-specific IgE.

242 accompanied by lower levels of PNA-specific IgE and intestinal mucosal mast cells and eosinophils ov

243 s, as egg-specific and birch pollen-specific IgE was more common in Finland.

244 t result (>=3 mm) and/or a positive specific IgE level (>=0.35 kU/L) for common allergens.

245 as skin-prick test [SPT] and serum specific IgE [sIgE]) when studying time trends in allergic respir

246 tization was determined using serum-specific IgE and skin prick testing against a panel of five fungi

247 i-FcepsilonRIalpha mAbs more safely suppress IgE-mediated anaphylaxis and food allergy than divalent

248 subclasses might be a mechanism to suppress IgE-mediated allergic responses.

249 itoneal mast cells and completely suppressed IgE-mediated anaphylaxis.

250 We previously demonstrated that IgE-mediated anaphylaxis could be safely prevented in wi

251 Mechanistic study demonstrates that IgE induces neutrophil FcepsilonR1 expression, activates

252 direct cellular analysis, demonstrating that IgE production was not limited to type 2 immune response

253 th either esIgG(4) or esIgD; indicating that IgE-secreting plasma cells could originate from either s

254 The IgE response to CHX seems polyclonal.

255 The IgE-reactivity and allergenic activity of the hybrid cyc

256 rently affect the protein solubility and the IgE-binding capacities of both the soluble and insoluble

257 de ending of CHX is the main epitope for the IgE and is suitable as screening assay to detect CHX rea

258 ponse were dominant or semi-dominant for the IgE phenotype but did not cause immunodeficiency in the

259 In contrast to the IgE Fc fragment, the IgE Fc in intact IgE is significantly less asymmetricall

260 If the IgE binding sites on the allergens could be identified,

261 tations in nine of the 12 genes limiting the IgE response were dominant or semi-dominant for the IgE

262 pha provided long-lasting suppression of the IgE recall response beyond antibody treatment and fully

263 that lead to high reduction rate (K) of the IgE-binding property.

264 Allergen cross-linking of the IgE/FcepsilonRI complex activates these cells, inducing

265 e aimed to examine the effects of AIT on the IgE- and IgG subclass-expressing memory B cells.

266 structures of intact IgE suggesting that the IgE Fab is fixed relative to the Fc.

267 In contrast to the IgE Fc fragment, the IgE Fc in intact IgE is significant

268 a neuraminidase enzyme targeted towards the IgE receptor FcepsilonRI, and administering asialylated

269 s (NPs) for two reasons: to collect only the IgEs from the serum sample and to enhance the optical in

270 eted of IgG1 or IgG4 were compared for their IgE-blocking activity.

271 y of peptide-specific IgG4 to surmount their IgE counterpart seems to be important in established pea

272 orally administrated to mice that were then IgE-sensitized to milk proteins.

273 Three IgE-binding proteins were identified: legumin (Pru du 6)

274 IgE to peanut/tree nut allergens from three IgE test platforms.

275 Tissue IgE and IgG4 levels are elevated in AERD, and higher IgE

276 e was associated with progression from AD to IgE-mediated food allergy, and white race was associated

277 fteen genes encoded proteins contributing to IgE class switch recombination or B-cell receptor signal

278 these variant transcripts can later lead to IgE against the native molecule and also explain how ana

279 Binding of ligelizumab to IgE in a 2:1 stoichiometry induces an extended and twofo

280 known as the "alpha-Gal syndrome" relates to IgE specific for galactose-alpha-1,3-galactose (alpha-Ga

281 ndrome of mammalian meat allergy relating to IgE specific for galactose-alpha-1,3-galactose (alpha-Ga

282 eaved peanut allergen Ara h 6 in relation to IgE-binding.

283 istically promoted B-cell class switching to IgE and plasma cell differentiation.

284 n induced higher OVA-specific IgG1 and total IgE in serum, and increased eosinophilia and interleukin

285 essed for A fumigatus-specific IgE and total IgE.

286 sociated with asthma, allergic asthma, total IgE, environmental IgE, and FeNO in an independent cohor

287 amination of glycosylation patterns of total IgE from individuals with a peanut allergy and from non-

288 6 among asthmatics with high levels of total IgE was compared to the response in healthy controls.

289 d effector cell sensitization, reduced total IgE serum levels, protected mice from passive and active

290 ators, mucus hypersecretion, and serum total IgE.

291 In ANT, only the sIgE/total IgE rPru p 3 ratio shows added value (sensitivity 60% an

292 and higher peanut sIgE levels and sIgE/total IgE, but lower sIgG(4)/sIgE.

293 The fraction of allergen-specific/total IgE may be useful to predict patients at greater risk of

294 n tail tyrosine (ITT) motif in transmembrane IgE (mIgE) impairs the memory IgE response in mice.

295 Tropomyosin T-cell cross-reactivity, unlike IgE cross-reactivity, is dependent on structural stabili

296 enced early-mammal species in existence when IgE first developed.

297 However, whether IgE glycans differ in disease states or affect biologica

298 cepsilonRI on allergic effector cells, while IgE-ICs were noninflammatory because of reduced Fcepsilo

299 th and at the time of later biosampling with IgE sensitization against common food and inhalant aller

300 sensitization model, mice were injected with IgE to Dermatophagoides pteronyssinus (rDer p)2 and then